Find a Specialist by Postal Code | Page 11 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Mahasweta Gooptu, MD Dana-Farber cancer Institute Boston Massachusetts United States
Satheesh Chonat, MD Children’s Healthcare of Atlanta Atlanta Georgia United States
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Gabrielle Meyers, MD OHSU Hospital Portland Oregon United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Staci Arnold, MD, MBA, MPH Children's Healthcare of Atlanta Atlanta Georgia United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Gregory Abel, MD, MPH Dana-Farber Cancer Institute Boston Massachusetts United States
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Courtney DiNardo, MD MD Anderson Cancer Center Houston Texas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
Michael Keng, MD University of Virginia Cancer Center Charlottesville Virginia United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Joseph Oved, MD Children's Hospital of Philadelphia Philadelphia Pennsylvania United States
  • Aplastic Anemia
  • Pediatric
Jamile M. Shammo, MD, FASCP, FACP Rush University Medical Center Chicago Illinois United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Andre Larochelle, MD, PhD National Institutes of Health - National Heart, Lung, and Blood Institute Bethesda Maryland United States
Catherine J. Lee, MD Huntsman Cancer Center, University of Utah Salt Lake City Utah United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
David Jacobsohn, MD, ScM Children's National Washington District Of Columbia United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Graft Versus Host Disease (GVHD)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
  • Pediatric
Mary Armanios, MD Johns Hopkins University Baltimore Maryland United States
Joseph H Antin, MD Dana-Farber Cancer Institute Boston Massachusetts United States
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Amy E. DeZern, MD, MHS Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Imad Tabbara, MD The George Washington Cancer Center Washington District Of Columbia United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Zhuoer Xie, MD, MS Moffitt Cancer Center Tampa Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Uma Borate, MBBS The Ohio State University Comprehensive Cancer Center Columbus Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Michael Byrne, DO Vanderbilt Medical Center Nashville Tennessee United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Barry Skikne, MD Westwood Medical Pavilion and the Richard and Annette Bloch Cancer Care Pavilion Westwood Kansas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)